InsiderClue
← All stocks

Organon & Co.

OGN Net buying
CIK 0001821825 #1600 in the set updated 18 Sep 2026
Bought (120 mo)
$1.66M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$200.31K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$200.31K
1 of 1 sales
Net
+$1.46M
+$1.46M against sales at will

By person

23 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
COX CARRIE SMITH
Executive Chair
$602.35K (2)
—
+$602.35K
90,338
0.0344%
$1.23M
+624.5%
Holzbaur Lynette
SVP and Corporate Controller
$353.08K (1)
—
+$353.08K
52,851
0.0201%
$717.19K
+386.7%
Ali Kevin
Chief Executive Officer
$299.37K (1)
—
+$299.37K
282,731
0.1077%
$3.84M
+1,799%
Drinane Juliana Papa
Head of Mfg & Supply
—
$200.31K (1)
−$200.31K
18,475
0.0070%
$250.70K
+50.1%
Weaver Kirke
Gen. Counsel & Corp. Secy.
$123.99K (2)
—
+$123.99K
92,639
0.0353%
$1.26M
+2,144%
Francisco Ma. Fatima
Director
$101.37K (1)
—
+$101.37K
3,000
0.0011%
$40.71K
—
WALSH MATTHEW M
Chief Financial Officer
$100.55K (1)
—
+$100.55K
212,746
0.0810%
$2.89M
+32,530%
Falcione Aaron
Chief Human Resources Officer
$48.24K (1)
—
+$48.24K
101,431
0.0386%
$1.38M
+2,072%
Karp Daniel
Executive VP, Corp. Dev.
$28.83K (1)
—
+$28.83K
69,548
0.0265%
$943.77K
+245.9%
Morrissey Joseph T. Jr.
Interim CEO
—
—
—
123,123
0.0469%
$1.67M
+1,852%
Stahler Rachel A
Chief Information Officer
—
—
—
116,105
0.0442%
$1.58M
+1,465%
Nisita Vittorio
Head of Global Business Svcs
—
—
—
70,619
0.0269%
$958.30K
+1,731%
Fiedler Susanne
Chief Commercial Officer
—
—
—
53,113
0.0202%
$720.74K
+1,719%
DiMarco Kathryn
Corporate Controller
—
—
—
38,740
0.0148%
$525.70K
+4,724%
Arjona Ferreira Juan Camilo
Head of R&D & CMO
—
—
—
37,432
0.0143%
$507.96K
—
Milligan Sandra
Head of Research & Development
—
—
—
28,599
0.0109%
$388.09K
+1,230%
Ritter Geralyn S
Head of Ext. Affairs and ESG
—
—
—
10,755
0.0041%
$145.95K
+4,168%
Telman Deborah H
EVP GC & Corporate Secretary
—
—
—
7,688
0.0029%
$104.33K
—
LAZARUS ROCHELLE B
Director
—
—
—
635
0.0002%
$8.62K
0.0%
Leone Deborah R
Director
—
—
—
10
<0.0001%
$135.70
0.0%
Whiteford Grace Puma
Director
—
—
—
5
<0.0001%
$67.85
0.0%
Sharp Shalini
Director
—
—
—
2
<0.0001%
$27.14
0.0%
Merck & Co., Inc. entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Drinane Juliana Papa
5 Aug 2026
Head of Mfg & Supply
Sell
14,761
$13.57
$200.31K
Holzbaur Lynette
6 May 2026
SVP and Corporate Controller
Buy
26,448
$13.35
$353.08K
COX CARRIE SMITH
12 Nov 2025
Executive Chair
Buy indirect
65,400
$7.67
$501.76K
COX CARRIE SMITH
14 May 2025
Director
Buy
12,469
$8.07
$100.59K
Falcione Aaron
7 May 2025
Chief Human Resources Officer
Buy
5,500
$8.77
$48.24K
Karp Daniel
6 May 2025
Executive VP, Corp. Dev.
Buy
3,500
$8.24
$28.83K
Weaver Kirke
6 May 2025
Gen. Counsel & Corp. Secy.
Buy
8,045
$9.21
$74.05K
Ali Kevin
5 May 2025
Chief Executive Officer
Buy
34,000
$8.81
$299.37K
WALSH MATTHEW M
5 May 2025
Chief Financial Officer
Buy
11,400
$8.82
$100.55K
Weaver Kirke
22 Feb 2024
Gen. Counsel & Corp. Secy.
Buy
2,720
$18.36
$49.94K
Francisco Ma. Fatima
19 Aug 2021
Director
Buy
3,000
$33.79
$101.37K
WALSH MATTHEW M
5 Aug 2021
Chief Financial Officer
Exercised, kept
22,343
$28.63
$639.68K
Stahler Rachel A
5 Aug 2021
Chief Information Officer
Exercised, kept
12,890
$28.63
$369.04K
Telman Deborah H
5 Aug 2021
EVP GC & Corporate Secretary
Exercised, kept
6,445
$28.63
$184.52K

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 256,219,868
History held since 4 Jun 2021